TCG Crossover Management’s RayzeBio RYZB Stock Holding History
Bought
Maintained
Sold
TCG Crossover Management's RYZB Position: Q1 2024 in Review
TCG Crossover Management sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 869,908 shares — an estimated $54.1M sold.
TCG Crossover Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $54.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.
- TCG Crossover Management reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
- TCG Crossover Management sold 869,908 RayzeBio shares in Q1 2024, an estimated $54.1M.
- TCG Crossover Management first reported a position in RayzeBio in Q3 2023 and held it in 2 quarters.
- TCG Crossover Management's RayzeBio position peaked at $54.1M in Q4 2023.
- 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.
Based on TCG Crossover Management's 13F filing for Q1 2024, filed 15 May 2024.